BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 33 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,454,220 | +121.7% | 20,000,000 | +110.5% | 0.06% | +96.9% |
| Q1 2023 | $6,969,571 | +3.0% | 9,500,000 | -36.7% | 0.03% | -3.0% |
| Q4 2022 | $6,763,500 | -23.9% | 15,000,000 | 0.0% | 0.03% | -35.3% |
| Q3 2022 | $8,892,000 | +6.1% | 15,000,000 | 0.0% | 0.05% | +13.3% |
| Q2 2022 | $8,384,000 | -6.7% | 15,000,000 | 0.0% | 0.04% | 0.0% |
| Q1 2022 | $8,987,000 | +204.7% | 15,000,000 | +275.0% | 0.04% | +275.0% |
| Q4 2021 | $2,949,000 | -94.8% | 4,000,000 | -88.6% | 0.01% | -95.2% |
| Q2 2021 | $57,050,000 | – | 35,000,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |